ClinicalTrials.Veeva

Menu

COPD Assessment Test Can Predict Depression

H

Hallym University

Status

Unknown

Conditions

Depression,
COPD

Study type

Observational

Funder types

Other

Identifiers

NCT01727219
2011-I010

Details and patient eligibility

About

The frequency of depression in COPD patients are substantial and early detection and prevention of depression is critical.

Recently, COPD assessment test (CAT) was developed and validated to assess the impact of COPD on patients' quality of life.

In this prospective study, we will investigate the predictive utility of CAT for predicting depression in COPD patients.

Full description

This study is aimed to investigate the association between the COPD Assessment Test (CAT) and depression in stable COPD patients. Stable COPD patients will be enrolled from the tertiary hospitals. All patients will undergo lung function tests. The Korean versions of the CAT (COPD assessment test) and Patient Health Questionnaire-9 (PHQ-9) will be used to assess COPD symptoms and depressive disorder, respectively.

We will compare the depresssion frequency among GOLD classifications of airway limitation and among the four CAT groups. And. we will also investigate which items of the CAT are the strongest indicators of depression.

Enrollment

600 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COPD patients who aged > or = 40 years

Exclusion criteria

  • acute exacerbation within 3 months
  • bronchial asthma or an increase in FEV1 of more than 12% of the predicted value with the use of 400 µg of albuterol.
  • other lung diseases such as bronchiectasis, interstitial lung disease, and tuberculosis-destroyed lungs.
  • who denied to consent.

Trial contacts and locations

1

Loading...

Central trial contact

Sunghoon Park, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems